The management of febrile neutropenia in the posaconazole era: a new challenge?

Haematologica. 2012 Jul;97(7):963-5. doi: 10.3324/haematol.2012.062166.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Fever / drug therapy*
  • Fever / etiology
  • Fungi / drug effects
  • Fungi / growth & development
  • Galactose / analogs & derivatives
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute / therapy
  • Mannans / analysis
  • Mycoses / complications
  • Mycoses / etiology
  • Mycoses / prevention & control*
  • Neutropenia / complications
  • Neutropenia / etiology
  • Neutropenia / prevention & control*
  • Polymerase Chain Reaction
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Mannans
  • Triazoles
  • galactomannan
  • posaconazole
  • Galactose